Information on WHO Approved Vaccines

Definition of a fully vaccinated individual:

A person is considered to be fully vaccinated 2 weeks after receiving the final recommended vaccine dose(s) of a WHO-approved vaccine or vaccine combination as indicated below.

On Thursday 16th December, 2021, the World Health Organization (WHO) released updated guidelines on COVID-19 vaccination, which indicate that any of the COVID-19 vaccines which have received a WHO Emergency Use Listing (EUL) may be used interchangeably.

Thus means that persons who received 2 doses of any combination of WHO approved COVID-19 vaccines with a 2-dose regimen will now be considered fully vaccinated two weeks after receipt of the final dose. Persons who received a single dose of a Johnson & Johnson vaccine will continue to be considered fully vaccinated two weeks after receipt of the vaccine.

The following COVID-19 Vaccines have received WHO EUL approval:

  • Pfizer-BioNTech - Approved 31st December 2020
  • AstraZeneca - Approved 15th  February 2021
  • Janssen (Johnson and Johnson) - Approved 12th  March 2021
  • Moderna-NIAID - Approved 30th  April 2021
  • Sinopharm BIBP- Approved 7th  May 2021
  • Sinovac-CoronaVac - Approved 1st  June 2021
  • Covaxin BBV152 – Approved 3rd November, 2021
  • Covovax - Approved 17th December, 2021
  • Novavax - NVX-CoV2373/Nuvaxovid - Approved 20th December, 2021

Ministry of Health
4-6 Queen's Park East
Port-of-Spain 101002
Trinidad and Tobago

+1 (868)-217-4MOH (4664)


Ambulance: 811

Police: 999

Fire: 990

ODPM: 511

TEMA: 211


Insect Vector Control: 800-IVCD

Chemistry, Food and Drugs: 800-CFDD

Chronic Disease Assistance: 800-CDAP